CMS is moving forward with multiple policies—effectively based on reducing reimbursement to hospitals—that have been deemed unlawful in court, according to the 2020 OPPS final rule, released Friday, November 1.
CMS is accepting comments until November 29 on a proposal to collect acquisition cost data from hospitals participating in the 340B drug discount program.
A federal judge rejected CMS’ motion to reconsider or issue a stay on her September order to vacate cuts to reimbursement to grandfathered off-campus provider-based departments.
CMS’ proposal mandating the disclosure of negotiated charges between hospitals and payers may exceed the agency’s legal authority and would have limited benefit to patients, according to the AHA.
Take an in-depth look at the 2020 IPPS final rule to ensure your organization is ready for a major revision to the hospital wage index calculation and more.
